Iryrna Kriachok

Statistics

Publications

Citations

324

H-Index

Active since

2020

Affiliations

Dana-Farber Cancer Institute(Current)

Iryrna Kriachok is an author at Dana-Farber Cancer Institute specializing in multiple myeloma therapy, hematologic malignancy pharmacotherapy, and medicine.

Publications per year

2020–2020

Publications

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Sebastian Grosicki, Maryana Simonova, Ivan Špıčka et al. · The Lancet · 2020 · 324 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–1 of 1